-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

New Scientific Discoveries

Symposia: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure Program: Scientific Workshops
Friday, December 6, 2024: 4:06 PM-4:56 PM
Room 6CF (San Diego Convention Center)
Moderators:
Akiko Shimamura, MD, PhD, Boston Children's Hospital and Alejandro Ferrer, PhD, Mayo Clinic
Disclosures:
No relevant conflicts of interest to declare.

In this session, investigators will present results from emerging scientific studies and how the new knowledge is impacting clinical care.

Akiko Shimamura, MD, PhD

Boston Children's Hospital, Boston, MA

Sean Harrop

Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Lili Kotmayer, MD, PhD

St. Jude Children's Research Hospital, Memphis, TN

Kristen E. Schratz, MD

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD; Johns Hopkins University School of Medicine, Baltimore, MD

Agnieszka D. Czechowicz, MD, PhD

Stanford University, Stanford, CA

Maryam Rafati, MD, PhD

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD